Health
FDA Approves Tecentriq Plus Chemotherapy for Stage III dMMR Colon Cancer
The FDA approved Tecentriq plus chemotherapy for stage III dMMR colon cancer after the ATOMIC trial showed a 50% cut in recurrence risk.
Health
Health reporting from Forever News Media: medical research, public health and wellbeing, checked against primary sources.
